Moreover, in the stratification analysis of the medication, RA patients receiving the CHP in combination with WM treatment showed a trend of reduced risk of IS compared with those receiving WM only, with the exception of RA patients taking TNF-antagonist ( Table 2 ).
← all excerpts
Adjunctive Chinese Herbal Products Therapy Reduces the Risk of Ischemic Stroke Among Patients With Rheumatoid Arthritis.
1
—
—